X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs SUN PHARMA - Comparison Results

WOCKHARDT    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT SUN PHARMA WOCKHARDT/
SUN PHARMA
 
P/E (TTM) x -19.6 32.7 - View Chart
P/BV x 1.4 2.7 50.1% View Chart
Dividend Yield % 0.0 0.5 0.6%  

Financials

 WOCKHARDT   SUN PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
SUN PHARMA
Mar-18
WOCKHARDT/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,012701 144.5%   
Low Rs532433 122.7%   
Sales per share (Unadj.) Rs355.9110.4 322.3%  
Earnings per share (Unadj.) Rs-60.311.0 -549.1%  
Cash flow per share (Unadj.) Rs-46.817.2 -271.4%  
Dividends per share (Unadj.) Rs0.012.00 0.5%  
Dividend yield (eoy) %00.4 0.4%  
Book value per share (Unadj.) Rs257.8158.8 162.3%  
Shares outstanding (eoy) m110.632,399.26 4.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.25.1 42.2%   
Avg P/E ratio x-12.851.6 -24.8%  
P/CF ratio (eoy) x-16.532.9 -50.2%  
Price / Book Value ratio x3.03.6 83.9%  
Dividend payout %018.2 -0.1%   
Avg Mkt Cap Rs m85,3791,360,021 6.3%   
No. of employees `0006.317.8 35.2%   
Total wages/salary Rs m9,37153,671 17.5%   
Avg. sales/employee Rs Th6,295.014,890.9 42.3%   
Avg. wages/employee Rs Th1,498.33,017.1 49.7%   
Avg. net profit/employee Rs Th-1,066.31,480.6 -72.0%   
INCOME DATA
Net Sales Rs m39,369264,895 14.9%  
Other income Rs m1,2028,388 14.3%   
Total revenues Rs m40,571273,282 14.8%   
Gross profit Rs m1856,081 0.0%  
Depreciation Rs m1,49514,998 10.0%   
Interest Rs m2,5555,176 49.4%   
Profit before tax Rs m-2,83044,295 -6.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582-9,505 37.7%   
Tax Rs m2578,452 3.0%   
Profit after tax Rs m-6,66926,338 -25.3%  
Gross profit margin %021.2 0.2%  
Effective tax rate %-9.119.1 -47.6%   
Net profit margin %-16.99.9 -170.4%  
BALANCE SHEET DATA
Current assets Rs m33,796316,359 10.7%   
Current liabilities Rs m26,917198,643 13.6%   
Net working cap to sales %17.544.4 39.3%  
Current ratio x1.31.6 78.8%  
Inventory Days Days7995 83.7%  
Debtors Days Days89108 82.9%  
Net fixed assets Rs m39,664213,178 18.6%   
Share capital Rs m5532,399 23.1%   
"Free" reserves Rs m27,968378,606 7.4%   
Net worth Rs m28,522381,006 7.5%   
Long term debt Rs m21,73117,721 122.6%   
Total assets Rs m81,620643,028 12.7%  
Interest coverage x-0.19.6 -1.1%   
Debt to equity ratio x0.80 1,638.2%  
Sales to assets ratio x0.50.4 117.1%   
Return on assets %-5.04.9 -102.8%  
Return on equity %-23.46.9 -338.2%  
Return on capital %-7.710.0 -76.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80740,816 24.0%   
Fx outflow Rs m1,78930,143 5.9%   
Net fx Rs m8,01910,673 75.1%   
CASH FLOW
From Operations Rs m68439,072 1.8%  
From Investments Rs m6,302-33,708 -18.7%  
From Financial Activity Rs m-7,695-15,393 50.0%  
Net Cashflow Rs m-664-7,359 9.0%  

Share Holding

Indian Promoters % 74.5 63.7 117.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 5.1 44.8%  
FIIs % 7.7 23.0 33.5%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 8.3 185.5%  
Shareholders   67,757 133,026 50.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare WOCKHARDT With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 16, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS